Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
HUNTINGTON BEACH, Calif., May 8 /PRNewswire-FirstCall/ -- WayPoint Biomedical, Inc., a subsidiary of WayPoint Biomedical Holdings, Inc. (OTC: WYPH) is announcing the following corporate...
HUNTINGTON BEACH, Calif., April 5 /PRNewswire-FirstCall/ -- WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) has received a subpoena from the Securities and Exchange Commission requesting...
HUNTINGTON BEACH, Calif., March 14 /PRNewswire-FirstCall/ -- WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) has contacted and stated their position to the SEC, where WayPoint denies any...
HUNTINGTON BEACH, Calif., March 13 /PRNewswire-FirstCall/ -- WayPoint Biomedical Holdings, Inc. (OTC:WYPH) CEO, Mr. Steven Fox, will address the temporary ten day suspension of their share...
HUNTINGTON BEACH, Calif., Oct. 6 /PRNewswire/ -- WayPoint Biomedical, Inc., a subsidiary of WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) is proud to announce that it has selected...
HUNTINGTON BEACH, Calif., Sept. 12 /PRNewswire/ -- WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) has signed a multi-year lease with First Huntington Capital, L.P. for additional office...
HUNTINGTON BEACH, Calif., Aug. 29 /PRNewswire-FirstCall/ -- WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) has received Food & Drug Administration (FDA) clearance for their two new...
HUNTINGTON BEACH, Calif., July 26 /PRNewswire-FirstCall/ -- WayPoint Biomedical, Inc. (Pink Sheets: WYPH) has expanded the criteria and timeline of their Letter of Intent (LOI) with Australian...
HUNTINGTON BEACH, Calif., July 12 /PRNewswire-FirstCall/ -- WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) has been accepted as a full member into the Health Industry Representatives...
HUNTINGTON BEACH, Calif., June 29 /PRNewswire-FirstCall/ -- WayPoint Biomedical, Inc. (Pink Sheets: WYPH), has received extremely promising results from a recently completed clinical study to...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 2189 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 18420 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 9162 | 1.577E-5 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 72895 | 1.99E-6 | CS |
| 156 | -0.050299 | -99.9980119284 | 0.0503 | 0.12 | 1.0E-6 | 89453 | 0.02685259 | CS |
| 260 | -0.000999 | -99.9 | 0.001 | 0.25 | 1.0E-6 | 86928 | 0.05646366 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
